# Varenicline and Alcohol in Inpatient Addictions Program (IAP)

> **NCT01169610** · PHASE3 · TERMINATED · sponsor: **Mayo Clinic** · enrollment: 1 (actual)

## Conditions studied

- Alcoholism
- Nicotine Dependence

## Interventions

- **DRUG:** Varenicline

## Key facts

- **NCT ID:** NCT01169610
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-01
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2019-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01169610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01169610, "Varenicline and Alcohol in Inpatient Addictions Program (IAP)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01169610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*